BELLUS Health Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.07 |
Market Cap |
$354.16 M |
Shares Outstanding |
66.87 M |
Public Float |
- |
BELLUS Health Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
66.87 M |
Public Float |
- |
BELLUS Health Inc. | |
Stock Exchange | Toronto Stock Exchange Prices |
EPS |
CAD0.09 |
Market Cap |
CAD467.99 M |
Shares Outstanding |
158.11 M |
Public Float |
115.8 M |
Address |
275 Armand-Frappier boulevard Laval Québec H7V 4A7 Canada |
Employees | - |
Website | http://www.bellushealth.com |
Updated | 07/08/2019 |
BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on April 12, 2012 and is headquartered in Laval, Canada. |